ArticleFrontiers in immunology2023

CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma.

Ioana Sonya Ciulean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.